Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

June 09, 2016

UN governments adopted a Political Declaration on Ending AIDS during the UN’s High-Level Meeting on Ending AIDS in New York on June 8, 2016, in which governments have committed to reaching 30 million people with HIV treatment by 2020.

June 07, 2016

Proposal to reach 30 million people with HIV treatment by 2020 is crucial, but urgent scale-up of treatment needed in low-coverage areas to close deadly treatment gaps

June 06, 2016

Rohit Malpani, director of policy and analysis at Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, delivered the following remarks at Meeting the Challenge of Antimicrobial Resistance, an event hosted by the United Nations’ Every Woman Every Child movement.

June 02, 2016

India must resist pressure from US lawmakers and pharmaceutical industry groups to block access to key medicines for millions of people worldwide

May 26, 2016

New York/Ise-Shima/Geneva—As the leaders of the G7 countries gather in Ise-Shima, Japan over the next two days, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to make a bold commitment to prioritize a better global response to public health emergencies and to take action to encourage the research and development (R&D) and affordable pricing of critical medicines.

May 16, 2016

US officials are expected to use this week’s APEC meeting to discuss extending the length of monopoly market protection for biologic medicines and vaccines.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

May 11, 2016

Worst trade deal ever for access to medicines would restrict price-lowering generic competition and promote a broken innovation system

May 10, 2016

Gilead Sciences has been seeking patents in India for the hepatitis C drug sofosbuvir. The patent applications have been challenged by groups of people living with hepatitis C and HIV through "pre-grant oppositions." The patent just granted by India’s patent office was initially rejected in January 2015, just before President Obama’s visit to India, which was seen as vexing the US. Gilead appealed the rejection and the patent has now been granted.

May 06, 2016

Sharonann Lynch, HIV policy advisor at Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement on the release of the United Nations Secretary General report on HIV/AIDS ahead of the June UN High Level Meeting on HIV—“Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declarations on HIV and AIDS: On the Fast-Track to End the AIDS epidemic.”

Pages